Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Angelo M. De Marzo"'
Autor:
Srinivasan Yegnasubramanian, Janis M. Taube, Angelo M. De Marzo, Busra Ozbek, Carolina Gomes Alexandre, Onur Ertunc, Tracy Jones, Andrew Erickson, Jessica L. Hicks, Karen S. Sfanos, Gunes Guner, Igor Vidal
Background Most prostate cancers are "immune cold" and poorly responsive to immune checkpoint inhibitors. However, the mechanisms responsible for the lack of a robust antitumor adaptive immune response in the prostate are poorly understood, which hin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c591f71687247183a020de67df431d23
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/96552
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/96552
Autor:
Todd Cohen, Misop Han, Igor Vidal, Bruce J. Trock, Stephanie Glavaris, Alan W. Partin, Angelo M. De Marzo, Brent Mabey, Steven Stone, Tracy Jones
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:The cell cycle progression (CCP) score and PTEN have never been evaluated together for metastasis-free survival (MFS) in a prostatectomy (RP) cohort of men with intermedi...
Autor:
Angelo M. De Marzo, Jeffrey J. Tosoian, Tamara L. Lotan, Ashley E. Ross, Mufaddal Mamawala, Liana B. Guedes, H. Ballentine Carter, Bruce J. Trock, Misop Han, Carlos L. Morais
Publikováno v:
Prostate cancer and prostatic diseases
Background: Up to half of men with Gleason score 6 (GS6) prostate cancers initially managed with active surveillance (AS) will eventually require definitive therapy, usually due to tumor grade reclassification during follow-up. We examined the associ
Autor:
Charles J. Bieberich, Angelo M. De Marzo, Srinivasan Yegnasubramanian, David M. Esopi, Qizhi Zheng, Gretchen K. Hubbard, Apurv Rege, Jessica Hicks, Mark C. Markowski, Alexia King
Publikováno v:
Prostate
Background Loss or mutation of PTEN alleles at 10q23 in combination with 8q24 amplification (encompassing MYC) are common findings in aggressive, human prostate cancer. Our group recently developed a transgenic murine model of prostate cancer involvi
Autor:
Angelo M. De Marzo, Misop Han, Elizabeth B. Humphreys, Fawaz Almutairi, Ashley E. Ross, Jessica Hicks, Stephanie Glavaris, Edward M. Schaeffer, Tamara L. Lotan, Debasish Sundi, Carlos L. Morais, Jeffrey J. Tosoian, Bruce J. Trock, Scott A. Tomlins
Publikováno v:
European Urology. 71:697-700
African-American (AA) men have a higher risk of lethal prostate cancer (PCa) compared to European-American (EA) men. However, the molecular basis of this difference, if any, remains unclear. In EA PCa, PTEN loss, but not ERG rearrangement, has been a
Autor:
Jessica L. Hicks, Sarah L. Poynton, Karen S. Sfanos, Angelo M. De Marzo, Lauren B. Peiffer, Sarah E. Ernst
Publikováno v:
The Prostate. 79(11)
Background Urogenital infection with Schistosoma haematobium is a risk factor for the development of squamous cell carcinoma of the urinary bladder. The pathophysiology is thought to be mediated in part by inflammation, cellular damage, and bladder r
Autor:
Ashley E. Ross, Angelo M. De Marzo, David M. Berman, Tamara L. Lotan, Tamara Jamaspishvili, Jeremy A. Squire, Howard I. Scher
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Genomic aberrations of the PTEN tumour suppressor gene are among the most common in prostate cancer. Inactivation of PTEN by deletion or mutation is identified in ∼20% of primary prostate tumour samples at radical prostatectomy and in as many as 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dc5495c3db67ca990b6a6ab6817a5d2
Autor:
Antoun Toubaji, Jonathan I. Epstein, Angelo M. De Marzo, Mehsati Herawi, Tamara L. Lotan, George J. Netto, Jessica Hicks, Roula Albadine, Carlos L. Morais
Publikováno v:
The Prostate. 75:1610-1619
BACKGROUND Prostatic ductal adenocarcinoma is an unusual and aggressive morphologic subtype of prostate cancer. PTEN gene deletion and ERG gene rearrangement are among the most common genomic changes in acinar prostate cancers. Though ductal adenocar
Autor:
Charles C. Guo, Yair Lotan, Mohammad Abufaraj, Beat Foerster, Alexander Bachmann, Kilian M. Gust, Nathalie Rioux-Leclercq, Alon Z. Weizer, Francesca Khani, Andrea Haitel, Malte Rieken, Vitaly Margulis, Christopher G. Wood, Angelo M. De Marzo, Shahrokh F. Shariat, Karim Bensalah, Brian D. Robinson, Jay D. Raman, Jose A. Karam
Publikováno v:
Journal of Urology
Journal of Urology, Elsevier, 2017, 198 (6), pp.1269-1277. ⟨10.1016/j.juro.2017.06.096⟩
Journal of Urology, 2017, 198 (6), pp.1269-1277. ⟨10.1016/j.juro.2017.06.096⟩
Journal of Urology, Elsevier, 2017, 198 (6), pp.1269-1277. ⟨10.1016/j.juro.2017.06.096⟩
Journal of Urology, 2017, 198 (6), pp.1269-1277. ⟨10.1016/j.juro.2017.06.096⟩
To our knowledge the frequency and prognostic significance of PTEN protein expression in upper tract urothelial carcinoma have not yet been investigated in large studies. We analyzed PTEN protein status and its association with disease recurrence and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd398a1c541e0285e61ba70b8aa6d38
https://hal.archives-ouvertes.fr/hal-02449063
https://hal.archives-ouvertes.fr/hal-02449063
Autor:
Thomas U. Ahearn, Massimo Loda, Carlos De Morais, Travis Gerke, Jennifer R. Rider, Meir J. Stampfer, Michelangelo Fiorentino, Kathryn M. Wilson, Angelo M. De Marzo, Lorelei A. Mucci, Tamara L. Lotan, Andreas Pettersson, Stephen P. Finn, Jessica Hicks, Ericka M. Ebot, Edward Giovannucci
Publikováno v:
Journal of Urology. 193